CLINICAL TRIALS OFFICE
CLINICAL TRIALS OFFICE
批准号:
8491592
负责人:
DANIEL M SULLIVAN
金额:
$29.95万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至
关键词:
Adverse eventBudgetsCancer CenterCancer Center Support GrantCancer ControlCancer Prevention TrialClinicalClinical InvestigatorClinical ResearchClinical TrialsCost Effective ManagementData CollectionDevelopmentDiseaseEducationEnrollmentEnsureGrowthInstructionInterventionIntervention StudiesIntervention TrialMedical ResearchMissionPatientsPeer ReviewPhasePreventionPreventive InterventionPrincipal InvestigatorProtocols documentationQualifyingRecordsReportingResearchResearch InfrastructureResearch PersonnelScreening procedureServicesSupportive careTraining and Educationbasecost effectivedata managementprogramsresearch study
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY (See instructions):
The Clinical Trials Office's (CTO) mission is to support clinical investigators in the development and implementation of clinical research studies at the Moffitt Cancer Center. The infrastructure in place assists the investigators with the following activities:
¿ Assisting investigators in screening and enrolling patients for clinical studies.
¿ Providing data management support for clinical studies.
¿ Assisting the Principal Investigators in the compliant conduct of clinical studies, including assisting in the submission of required regulatory documents, annual reviews and adverse event reporting.
¿ Providing staff training and education pertaining to clinical studies.
¿ Coordinating and implementing protocol related orders for study patients.
¿ Preparing medical and research records for audits.
The CTO has seen an average combined accrual to clinical intervention, prevention intervention, and supportive care intervention trials of 2,856 subjects/year for FY's 2006-2010 (an average of 1,176 subjects/year for clinical intervention trials, 780 subjects/year for prevention intervention trials, and 872 subjects/year for supportive care intervention trials). FY 2010 was especially robust, with accruals of 1,287,2,406, and 1,001 subjects to clinical, prevention, and supportive care intervention trials, respectively. The
accrual to investigator-initiated trials (external peer reviewed + institutional) for all intervention studies has remained greater than 60% for all 5 years and was 84% in FY 2010. Clearly, these accrual levels, as well as the complexity and increased data collection requirements of current trials, have necessitated growth of the CTO and demand increased efficiency.
The CTO operates efficiently for the cost effective management of clinical trials at the Cancer Center. The accrual to all intervention, prevention intervention and supportive care intervention trials continues to increase on a yearly basis. The Core requests CCSG Support of $570,611, which is 13% of its operational budget.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
CRM1 INHIBITORS SENSITIZE MULTIPLE MYELOMA CELLS TO TOPOISOMERASE II AND PROTEASOME INHIBITORS
-
批准号:8861643
-
项目类别:
-
资助金额:$41.38万
-
财政年份:2015
-
负责人:DANIEL M SULLIVAN
-
依托单位:
EARLY THERAPEUTICS DEVELOPMENT WITH PHASE II EMPHASIS
-
批准号:8544374
-
项目类别:
-
资助金额:$73.51万
-
财政年份:2011
-
负责人:DANIEL M SULLIVAN
-
依托单位:
EARLY THERAPEUTICS DEVELOPMENT WITH PHASE II EMPHASIS
-
批准号:8740463
-
项目类别:
-
资助金额:$36.76万
-
财政年份:2011
-
负责人:DANIEL M SULLIVAN
-
依托单位:
EARLY THERAPEUTICS DEVELOPMENT WITH PHASE II EMPHASIS
-
批准号:9122264
-
项目类别:
-
资助金额:$12.48万
-
财政年份:2011
-
负责人:DANIEL M SULLIVAN
-
依托单位:
EARLY THERAPEUTICS DEVELOPMENT WITH PHASE II EMPHASIS
-
批准号:8352532
-
项目类别:
-
资助金额:$66.16万
-
财政年份:2011
-
负责人:DANIEL M SULLIVAN
-
依托单位:
EARLY THERAPEUTICS DEVELOPMENT WITH PHASE II EMPHASIS
-
批准号:8919809
-
项目类别:
-
资助金额:$49.01万
-
财政年份:2011
-
负责人:DANIEL M SULLIVAN
-
依托单位:
Early Therapuetics with Phase II Emphasis
-
批准号:8014375
-
项目类别:
-
资助金额:$124.79万
-
财政年份:2006
-
负责人:DANIEL M SULLIVAN
-
依托单位:
Early Therapuetics with Phase II Emphasis
-
批准号:8257118
-
项目类别:
-
资助金额:$63.93万
-
财政年份:2006
-
负责人:DANIEL M SULLIVAN
-
依托单位:
DRUG SEQUENCING RESISTANCE IN MULTIPLE MYELOMA
-
批准号:2875944
-
项目类别:
-
资助金额:$14.11万
-
财政年份:1999
-
负责人:DANIEL M SULLIVAN
-
依托单位:
DRUG RESISTANCE TO INHIBITORS OF DNA TOPOISOMERASE II
-
批准号:2100358
-
项目类别:
-
资助金额:$16.63万
-
财政年份:1994
-
负责人:DANIEL M SULLIVAN
-
依托单位:
DRUG RESISTANCE TO INHIBITORS OF DNA TOPOISOMERASE II
-
批准号:2429778
-
项目类别:
-
资助金额:$18.22万
-
财政年份:1994
-
负责人:DANIEL M SULLIVAN
-
依托单位:
DRUG RESISTANCE TO INHIBITORS OF DNA TOPOISOMERASE II
-
批准号:2100359
-
项目类别:
-
资助金额:$27.05万
-
财政年份:1994
-
负责人:DANIEL M SULLIVAN
-
依托单位:
DRUG RESISTANCE TO INHIBITORS OF DNA TOPOISOMERASE II
-
批准号:2100360
-
项目类别:
-
资助金额:$17.52万
-
财政年份:1994
-
负责人:DANIEL M SULLIVAN
-
依托单位:
DNA TOPOISOMERASE ACTIVITY AND CANCER THERAPY
-
批准号:3079632
-
项目类别:
-
资助金额:$1.01万
-
财政年份:1987
-
负责人:DANIEL M SULLIVAN
-
依托单位:
DNA TOPOISOMERASE ACTIVITY AND CANCER THERAPY
-
批准号:3079629
-
项目类别:
-
资助金额:$6.31万
-
财政年份:1987
-
负责人:DANIEL M SULLIVAN
-
依托单位:
DNA TOPOISOMERASE ACTIVITY AND CANCER THERAPY
-
批准号:3079628
-
项目类别:
-
资助金额:$8.36万
-
财政年份:1987
-
负责人:DANIEL M SULLIVAN
-
依托单位:
DNA TOPOISOMERASE ACTIVITY AND CANCER THERAPY
-
批准号:3079631
-
项目类别:
-
资助金额:$8.49万
-
财政年份:1987
-
负责人:DANIEL M SULLIVAN
-
依托单位:
DNA TOPOISOMERASE ACTIVITY AND CANCER THERAPY
-
批准号:3079630
-
项目类别:
-
资助金额:$6.96万
-
财政年份:1987
-
负责人:DANIEL M SULLIVAN
-
依托单位:
DNA TOPOISOMERASE ACTIVITY AND CANCER THERAPY
-
批准号:3079627
-
项目类别:
-
资助金额:$3.23万
-
财政年份:1987
-
负责人:DANIEL M SULLIVAN
-
依托单位:
Clinical Protocol and Data Management Core
-
批准号:9209824
-
项目类别:
-
资助金额:$24.94万
-
财政年份:--
-
负责人:DANIEL M SULLIVAN
-
依托单位:
海外基金